Skip to main content

Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.

Publication ,  Journal Article
West, KL; Cardona, DM; Su, Z; Puri, PK
Published in: Am J Dermatopathol
May 2014

BACKGROUND: The distinction between dermatofibroma (DF), dermatofibrosarcoma protuberans (DFSP), and other benign and malignant cutaneous spindle cell lesions frequently requires immunohistochemical staining. CD34 and factor XIIIa are the most commonly used immunostains; however, they may exhibit aberrant expression and introduce the potential for misdiagnosis. There is some data supporting that p75 and S100A6 may be additional helpful immunohistochemical markers. METHODS: We undertook a large case series examining the use of CD34 and factor XIIIa as well as p75 and S100A6 in DF, cellular DF, DFSP, indeterminate fibrohistiocytic lesion, and scar. RESULTS: As expected, CD34 stained DFSP, although it was usually negative in DF. Factor XIIIa was generally positive in DF and negative in DFSP. There were exceptions in both cases of DF and DFSP. S100A6 was routinely negative in all entities studied. P75 was negative in all cases except DFSP, approximately half of which showed weak and/or patchy positivity. CONCLUSIONS: We conclude that to date, CD34 and factor XIIIa remain the most reliable immunohistochemical markers for DF and DFSP.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Dermatopathol

DOI

EISSN

1533-0311

Publication Date

May 2014

Volume

36

Issue

5

Start / End Page

414 / 419

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • S100 Proteins
  • Receptors, Nerve Growth Factor
  • Nerve Tissue Proteins
  • Immunohistochemistry
  • Humans
  • Histiocytoma, Benign Fibrous
  • Factor XIIIa
  • Diagnosis, Differential
  • Dermatology & Venereal Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
West, K. L., Cardona, D. M., Su, Z., & Puri, P. K. (2014). Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75. Am J Dermatopathol, 36(5), 414–419. https://doi.org/10.1097/DAD.0b013e3182a70396
West, Kelly L., Diana M. Cardona, Zuowei Su, and Puja K. Puri. “Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.Am J Dermatopathol 36, no. 5 (May 2014): 414–19. https://doi.org/10.1097/DAD.0b013e3182a70396.
West KL, Cardona DM, Su Z, Puri PK. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75. Am J Dermatopathol. 2014 May;36(5):414–9.
West, Kelly L., et al. “Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.Am J Dermatopathol, vol. 36, no. 5, May 2014, pp. 414–19. Pubmed, doi:10.1097/DAD.0b013e3182a70396.
West KL, Cardona DM, Su Z, Puri PK. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75. Am J Dermatopathol. 2014 May;36(5):414–419.

Published In

Am J Dermatopathol

DOI

EISSN

1533-0311

Publication Date

May 2014

Volume

36

Issue

5

Start / End Page

414 / 419

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • S100 Proteins
  • Receptors, Nerve Growth Factor
  • Nerve Tissue Proteins
  • Immunohistochemistry
  • Humans
  • Histiocytoma, Benign Fibrous
  • Factor XIIIa
  • Diagnosis, Differential
  • Dermatology & Venereal Diseases